Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Price Targets for Universal Health Services NYSE UHS

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
0
SHARES
25
VIEWS
Share on FacebookShare on Twitter

Analyst Sarah James from Cantor Fitzgerald maintains her Underweight rating on Universal Health Services (NYSE: UHS) but has increased the price target to $156 from $148. As of February 29, 2024, the average price target for UHS stands at $173.83, with a high forecast of $190.00 and a low forecast of $161.00, suggesting a 5.79% change.

Other analysts have provided their own price targets, including Credit Suisse at $163.00, Barclays at $142.00, and Deutsche Bank at $155 (up from $145). The varying opinions from analysts indicate a range of perspectives on Universal Health Services’ stock performance and price targets.

Universal Health Services, Inc. (UHS) Stock Soars on February 29, 2024: Positive Performance and Strong Opening

On February 29, 2024, Universal Health Services, Inc. (UHS) saw a positive performance in the stock market. According to data from CNN Money, UHS was trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over the past year and is currently in an upward trend.

The price of UHS shares increased by $3.68 since the market last closed, representing a 2.28% rise. The stock opened at $163.13, which was $1.40 higher than its previous close. This strong opening suggests that investors were optimistic about the company’s prospects on that day.

Universal Health Services, Inc. (UHS) Reports Strong Financial Performance for 2023: Revenue and EPS Growth Signals Stability and Potential

On February 29, 2024, Universal Health Services, Inc. (UHS) reported its financial performance for the past year and the fourth quarter. According to data from CNN Money, UHS generated a total revenue of $14.28 billion over the past year, which represents a 6.59% increase compared to the previous year. In the fourth quarter alone, the company brought in $3.70 billion in revenue, showing a 3.95% increase from the previous quarter.

In terms of net income, UHS reported a total of $717.79 million for the year, up 6.36% from the previous year. However, in the fourth quarter, the net income remained flat at $216.38 million. Despite the quarterly stagnation, the annual increase in net income is a positive sign for the company’s financial health.

Earnings per share (EPS) also saw significant growth for UHS. The company reported an EPS of $10.23 for the year, marking an 11.92% increase from the previous year. In the fourth quarter, the EPS rose to $3.16, showing a substantial 31.79% increase from the previous quarter.

Overall, UHS’s stock performance on February 29, 2024, reflects a strong financial performance over the past year, with steady revenue growth and increasing earnings per share. Investors may view these positive indicators as a sign of the company’s stability and potential for future growth.

Tags: UHS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable energy

Imperial Oil AMEX IMO Stock Analysis Impressive Performance and Growth Potential

Food Retailers Stock Bull Market

Etsy Unusual Options Activity Analysis Potential Market Shift on the Horizon

Analyst Sentiments Towards Mirum Pharmaceuticals A Mixed Bag

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com